These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36500804)

  • 1. Toxicity Assessment of [
    Hernández-Jiménez T; Cruz-Nova P; Ancira-Cortez A; Gibbens-Bandala B; Lara-Almazán N; Ocampo-García B; Santos-Cuevas C; Morales-Avila E; Ferro-Flores G
    Nanomaterials (Basel); 2022 Nov; 12(23):. PubMed ID: 36500804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Endoradiotherapy with Lu
    Luna-Gutiérrez M; Ocampo-García B; Jiménez-Mancilla N; Ancira-Cortez A; Trujillo-Benítez D; Hernández-Jiménez T; Ramírez-Nava G; Hernández-Ramírez R; Santos-Cuevas C; Ferro-Flores G
    Pharmaceutics; 2022 Mar; 14(4):. PubMed ID: 35456554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving Overall Survival and Quality of Life in Patients with Prostate Cancer and Neuroendocrine Tumors Using
    Luna-Gutiérrez M; Hernández-Ramírez R; Soto-Abundiz A; García-Pérez O; Ancira-Cortez A; López-Buenrostro S; Gibbens-Bandala B; Soldevilla-Gallardo I; Lara-Almazán N; Rojas-Pérez M; Ocampo-García B; Azorín-Vega E; Santos-Cuevas C; Ferro-Flores G
    Pharmaceutics; 2023 Jul; 15(7):. PubMed ID: 37514174
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis, chemical and biochemical characterization of Lu
    Ancira-Cortez A; Ferro-Flores G; Jiménez-Mancilla N; Morales-Avila E; Trujillo-Benítez D; Ocampo-García B; Santos-Cuevas C; Escudero-Castellanos A; Luna-Gutiérrez M
    Mater Sci Eng C Mater Biol Appl; 2020 Dec; 117():111335. PubMed ID: 32919684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical dosimetric studies of
    Meléndez-Alafort L; Ferro-Flores G; Santos-Cuevas C; Ocampo-García B; Turato S; Fracasso G; Bolzati C; Rosato A; De Nardo L
    Med Phys; 2021 Jul; 48(7):4064-4074. PubMed ID: 33966284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical translation of a PSMA inhibitor for
    Ferro-Flores G; Luna-Gutiérrez M; Ocampo-García B; Santos-Cuevas C; Azorín-Vega E; Jiménez-Mancilla N; Orocio-Rodríguez E; Davanzo J; García-Pérez FO
    Nucl Med Biol; 2017 May; 48():36-44. PubMed ID: 28193503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and preclinical evaluation of the 177Lu-DOTA-PSMA(inhibitor)-Lys3-bombesin heterodimer designed as a radiotheranostic probe for prostate cancer.
    Escudero-Castellanos A; Ocampo-García B; Ferro-Flores G; Santos-Cuevas C; Morales-Ávila E; Luna-Gutiérrez M; Isaac-Olivé K
    Nucl Med Commun; 2019 Mar; 40(3):278-286. PubMed ID: 30763290
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Trujillo-Benítez D; Luna-Gutiérrez M; Aguirre-De Paz JG; Cruz-Nova P; Bravo-Villegas G; Vargas-Ahumada JE; Vallejo-Armenta P; Morales-Avila E; Jiménez-Mancilla N; Oros-Pantoja R; Santos-Cuevas C; Azorín-Vega E; Ocampo-García B; Ferro-Flores G
    Pharmaceutics; 2024 Apr; 16(4):. PubMed ID: 38675193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Multidose Preparation of a Ready-to-Use
    Chakraborty A; Mitra A; Tawate M; Sahoo S; Lad S; Rakshit S; Gaikwad S; Basu S; Shimpi H; Banerjee S
    Cancer Biother Radiopharm; 2021 Oct; 36(8):682-692. PubMed ID: 34402687
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessment of the radiation absorbed dose produced by
    Azorín-Vega E; Rojas-Calderón E; Ferro-Flores G; Aranda-Lara L; Jiménez-Mancilla N; Nava-Cabrera MA
    Appl Radiat Isot; 2019 Apr; 146():66-71. PubMed ID: 30753987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, Synthesis and Preclinical Assessment of
    Trujillo-Benítez D; Luna-Gutiérrez M; Ferro-Flores G; Ocampo-García B; Santos-Cuevas C; Bravo-Villegas G; Morales-Ávila E; Cruz-Nova P; Díaz-Nieto L; García-Quiroz J; Azorín-Vega E; Rosato A; Meléndez-Alafort L
    Molecules; 2022 Jan; 27(1):. PubMed ID: 35011496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [
    Coria-Domínguez L; Vallejo-Armenta P; Luna-Gutiérrez M; Ocampo-García B; Gibbens-Bandala B; García-Pérez F; Ramírez-Nava G; Santos-Cuevas C; Ferro-Flores G
    Pharmaceuticals (Basel); 2022 May; 15(5):. PubMed ID: 35631416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between
    Nava-Cabrera M; Azorín-Vega E; Oros-Pantoja R; Aranda-Lara L
    Appl Radiat Isot; 2021 Oct; 176():109898. PubMed ID: 34418726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of
    Azorín-Vega E; Aranda-Lara L; Torres-García E; Santiago-Bañuelos JA
    Appl Radiat Isot; 2019 Apr; 146():24-28. PubMed ID: 30743222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [
    Vallejo-Armenta P; Ferro-Flores G; Santos-Cuevas C; García-Pérez FO; Casanova-Triviño P; Sandoval-Bonilla B; Ocampo-García B; Azorín-Vega E; Luna-Gutiérrez M
    Pharmaceuticals (Basel); 2022 Jun; 15(6):. PubMed ID: 35745648
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Ocampo-García B; Cruz-Nova P; Jiménez-Mancilla N; Luna-Gutiérrez M; Oros-Pantoja R; Lara-Almazán N; Pérez-Velasco D; Santos-Cuevas C; Ferro-Flores G
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38068876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and Dosimetry Assessment of
    Canseco-Hernández O; Ferro-Flores G; Jimenez-Mancilla N; Aranda-Lara L; Ocampo-Garcia B; Trujillo-Benitez D; Ancira-Cortés A; Morales-Avila E; Santos-Cuevas C
    J Nanosci Nanotechnol; 2021 Nov; 21(11):5449-5458. PubMed ID: 33980355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Albumin-Binding PSMA Ligands: Optimization of the Tissue Distribution Profile.
    Benešová M; Umbricht CA; Schibli R; Müller C
    Mol Pharm; 2018 Mar; 15(3):934-946. PubMed ID: 29400475
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Banerjee SR; Kumar V; Lisok A; Chen J; Minn I; Brummet M; Boinapally S; Cole M; Ngen E; Wharram B; Brayton C; Hobbs RF; Pomper MG
    Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2545-2557. PubMed ID: 31399803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Systematic Review and Meta-analysis of the Effectiveness and Toxicities of Lutetium-177-labeled Prostate-specific Membrane Antigen-targeted Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer.
    Sadaghiani MS; Sheikhbahaei S; Werner RA; Pienta KJ; Pomper MG; Solnes LB; Gorin MA; Wang NY; Rowe SP
    Eur Urol; 2021 Jul; 80(1):82-94. PubMed ID: 33840558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.